Anchor Science's Mission is enabling unobtrusive, accurate, and at will monitoring of temperature in diagnostic applications.
Motto:
Temperature (T) establishes the fundamental metric for physical and chemical sensors.
Who we are:
Anchor Science is a company with international partners, patent pending technology and experienced scientists.
What we do:
We develop contact T sensing elements in tailored size from inches to nanometers, and electrical response signal.
Our T sensing elements can be fabricated by digital printing.
The sensing element material is compatible with concurrent fabrication of biological, chemical and physical sensors, enabling formulation of sensing arrays for mapping multiple analytes.
We offer:
Prototypes of temperature sensing elements compatible with carbon nanotube based chemical or biochemical sensors.
IP for embedded applications of our temperature sensing elements in integrated circuits for T measurement, compensation, or control. The preferred applications are in conjunction with wireless communications, temperature monitoring/control of perishables, and health.
Consulting on uses of carbon nanotube based electrically conductive inks.
Materials on “Applications of Nanotechnology” for Curriculum development for use under Creative Commons License.
Anchor Science History
2005: Anchor Science is founded by Ewa S. Kirkor, Alexander Scheeline, and April Schricker.
Technical Breakthrough: Demonstrate Ohmic behavior of an ink-jet printed carbon nanocomposite at the European Coatings Conference "The Power of Ink-jet Materials III", December 1 -2, 2005, Berlin, Germany.
2007: Foresight Science and Technology gives “GO” evaluation to our temperature sensing nanocomposites.
Initial National Priorities for Comparative Effectiveness Research Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options. Comparative effectiveness research (CER) identifies what works best for which patients under what circumstances. Congress, in the American Recovery and Reinvestment Act (ARRA) of 2009, tasked the Institute of Medicine (IOM) to recommend national priorities for research questions to be addressed by CER and supported by ARRA funds. In its 2009 report, Initial National Priorities for Comparative Effectiveness Research, the authoring committee establishes a working definition of CER, develops a priority list of research topics, and identifies the necessary requirements to support a robust and sustainable CER enterprise.